Bioxytran, Inc.
BIXT
$0.03
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.85% | 30.57% | 27.96% | 105.35% | -141.50% |
| Total Depreciation and Amortization | 10.53% | 0.00% | 180.00% | 66.67% | -5.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.05% | 129.74% | -510.00% | -498.95% | 128.08% |
| Change in Net Operating Assets | 180.88% | -47.01% | 13.31% | -70.27% | 9,906.25% |
| Cash from Operations | -42.62% | -85.30% | 43.54% | -14.79% | -52.65% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 48.76% | 84.26% | -2,271.43% | 100.00% |
| Cash from Investing | -- | 48.76% | 84.26% | -2,271.43% | 100.00% |
| Total Debt Issued | -- | -81.18% | -60.95% | 836.63% | 67.34% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 20.72% | 568.42% | -48.34% | 29.41% | 67.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,762.50% | 1,779.32% | -46.23% | -134.29% | 95.03% |